NCT06513208

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

Ketorolac Effects on Post-operative Pain and Lumbar Fusion: a Double Blind Randomized Controlled Trial

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: University of Maryland St. Joseph Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Accepted

Summary

A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.

Conditions

• Lumbar Spinal Fusion

Interventions

Type	Name	Description
DRUG	Ketorolac Tromethamine	IV Ketorolac 15mg every 6 hours, x 4 doses
DRUG	Placebo	IV saline as placebo

Timeline

• Start date: 2026-01-01
• Primary completion: 2027-06-01
• Completion: 2027-06-01
• First posted: 2024-07-22
• Last updated: 2025-12-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study